These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35491081)

  • 1. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
    Ponto J; Bell RB
    Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):315-324. PubMed ID: 35491081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Melanoma - A Review of Systemic Therapies.
    Lee KA; Nathan P
    Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Considerations and Systemic Therapy of Melanoma.
    Gamboa AC; Lowe M; Yushak ML; Delman KA
    Surg Clin North Am; 2020 Feb; 100(1):141-159. PubMed ID: 31753109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and Neoadjuvant Therapeutics for the Treatment of Cutaneous Melanoma.
    Bruce WJ; Koljonen JL; Romanelli MR; Khan AU; Neumeister MW
    Clin Plast Surg; 2021 Oct; 48(4):651-658. PubMed ID: 34503725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant use of ipilimumab in locally advanced melanoma.
    Howie LJ; Tyler DS; Salama AK
    J Surg Oncol; 2015 Dec; 112(8):841-3. PubMed ID: 26768512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
    McKean MA; Amaria RN
    Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for melanoma: past, present, and future.
    Therien AD; Chime-Eze CM; Rhodin KE; Beasley GM
    Surg Oncol; 2024 Oct; 56():102127. PubMed ID: 39236515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations.
    Shalata W; Attal ZG; Solomon A; Shalata S; Abu Saleh O; Tourkey L; Abu Salamah F; Alatawneh I; Yakobson A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Pelster MS; Amaria RN
    Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant immunotherapy for melanoma.
    Thomas D; Bello DM
    J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
    Czarnecka AM; Ostaszewski K; Błoński P; Szumera-Ciećkiewicz A; Kozak K; Placzke J; Borkowska A; Terlecka A; Rogala P; Świtaj T; Sałamacha M; Mitręga-Korab B; Krotewicz M; Dudzisz-Śledź M; Rutkowski P
    Eur J Surg Oncol; 2024 Jul; 50(7):108382. PubMed ID: 38763112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Managing cutaneous melanoma].
    Thomas L; Cochran AJ
    Cancer Radiother; 1998 Dec; 2(6):732-46. PubMed ID: 9922781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. News from the melanoma sessions of the European Cancer Congress 2017.
    Rutkowski P; Kozak K
    BMC Med; 2017 Mar; 15(1):57. PubMed ID: 28302128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy for malignant melanoma].
    Zaremba A; Zimmer L; Griewank KG; Ugurel S; Roesch A; Schadendorf D; Livingstone E
    Internist (Berl); 2020 Jul; 61(7):669-675. PubMed ID: 32462249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapies.
    Perez MC; Depalo DK; Zager JS
    Expert Opin Drug Saf; 2023; 22(9):789-797. PubMed ID: 37551723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives.
    Testori AAE; Ribero S; Indini A; Mandalà M
    Am J Clin Dermatol; 2019 Dec; 20(6):817-827. PubMed ID: 31177507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for Non-melanoma Skin Cancer.
    Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
    Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.
    Long GV; Menzies AM; Scolyer RA
    J Clin Oncol; 2023 Jun; 41(17):3236-3248. PubMed ID: 37104746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
    McKean MA; Amaria RN
    Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.